Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Transcode Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 17 | +17 |
| Shares | 0 | 2.44M | +2.44M |
| Value | $0 | $7.28M | +$7.28M |
New holders (17)
Institutions that held Transcode Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 1,270,500 | $3.80M | 1.13% |
| Kepos Capital LP | 300,000 | $897.0K | 0.06% |
| Worth Venture Partners, LLC | 295,518 | $884.0K | 0.40% |
| Vanguard Group Inc | 200,117 | $598.0K | 0.00% |
| Citadel Advisors LLC | 90,774 | $271.0K | 0.00% |
| Two Sigma Investments, LP | 76,645 | $229.0K | 0.00% |
| ACT Capital Management, LLC | 50,000 | $150.0K | 0.08% |
| Two Sigma Securities, LLC | 33,314 | $100.0K | 0.02% |
| National Asset Management, Inc. | 25,000 | $75.0K | 0.00% |
| State Street Corp | 20,600 | $62.0K | 0.00% |
| Virtu Financial LLC | 18,064 | $54.0K | 0.00% |
| Geode Capital Management, LLC | 17,023 | $50.0K | 0.00% |
| BlackRock Inc. | 16,366 | $49.0K | 0.00% |
| Shay Capital LLC | 15,060 | $45.0K | 0.01% |
| UBS Group AG | 5,337 | $16.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,473 | $4.00K | 0.00% |
| Wells Fargo & Company | 38 | $0 | 0.00% |
Sold out (0)
Institutions that held Transcode Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.